MiNK Therapeutics, Inc. (INKT) has 5 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Sept. 2, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 2, 2026 filed Sept. 1, 2026 | WIINBERG ULF Director | $14,005 | 1,279 | +6% | No | |
|
|
||||||
| Sept. 2, 2026 filed Sept. 1, 2026 | Holcomb John Bradley Director | $13,501 | 1,233 | +36% | No | |
|
|
||||||
| Sept. 2, 2026 filed Sept. 1, 2026 | Behner Peter Director | $16,261 | 1,485 | +6% | No | |
|
|
||||||
| Sept. 2, 2026 filed Sept. 1, 2026 | Ryan Barbara Director | $17,761 | 1,622 | +7% | No | |
|
|
||||||
| Sept. 2, 2026 filed Sept. 1, 2026 | Corvese Brian Director | $17,881 | 1,633 | +3% | No | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free